Copper lowering treatment of inflammatory and fibrotic diseases
CA 2490541 A1 · Owner: The Regents Of The University Of Michigan · Inventors: Brewer, George J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the field of prophylaxis and therapy for inflammatory and/or fibrotic diseases which include responses to injuries. In particular, the present invention is related to agents that can bind or complex copper such as thiomolybdate and to the use of these agents , in the prevention and treatment of inflammatory and/or fibrotic diseases. Exemplary thiomolybdates include monodi-, tri- and tetrathiomolybdate; , these agents are administered to patients to prevent and/or treat inflammatory and/or fibrotic diseases, such as pulmonary disease including pulmonary fibrosis and acute respiratory distress syndrome liver disease including , liver cirrhosis …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.